T5O0 Share Price Performance
€0.14
-2.45 (-94.52%)
Price €0.14
Share Price€0.14
bioXXmed AG Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
T5O0 Community Narratives
There are no narratives available yet.
Recent T5O0 News & Updates
bioXXmed AG Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.73
- Gross Margin
- 100.00%
- Net Profit Margin
- -28,540.14%
- Debt/Equity Ratio
- 0%
bioXXmed AG Competitors
Snowflake Analysis
About T5O0
- Founded
- 2000
- Employees
- 1
- CEO
- WebsiteView website
bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. The company was founded in 2000 and is based in Darmstadt, Germany.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
German Market Performance
- 7 Days: -1.2%
- 3 Months: -0.7%
- 1 Year: 12.1%
- Year to Date: 12.0%
Over the last 7 days, the market has dropped 1.2%, driven by a pullback of 4.6% in the Consumer Discretionary sector. In contrast to the last week, the market is actually up 12% over the past year. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›